These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13959772)

  • 1. Dihydroxyphenylalanine in extrapyramidal disease.
    FRIEDHOFF AJ; HEKIMIAN L; ALPERT M; TOBACH E
    JAMA; 1963 Apr; 184():285-6. PubMed ID: 13959772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Features of medical therapy of Parkinson's syndrome].
    BIRKMAYER W; MENTASTI M
    Wien Klin Wochenschr; 1962 Oct; 74():700-2. PubMed ID: 13971141
    [No Abstract]   [Full Text] [Related]  

  • 3. [The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].
    BIRKMAYER W; HORNYKIEWICZ O
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1962; 203():560-74. PubMed ID: 13971142
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.
    MCGEER PL; BOULDING JE; GIBSON WC; FOULKES RG
    JAMA; 1961 Sep; 177():665-70. PubMed ID: 13773933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary report on rigidyl therapy of extrapyramidal movement disorders].
    HANSEN B; TASCHABITSCHER H
    Wien Med Wochenschr; 1952 Jul; 102(29/30):551-4. PubMed ID: 12995613
    [No Abstract]   [Full Text] [Related]  

  • 6. Paralysis agitans and L-dopa drug therapy.
    Redden M
    Nurs Times; 1972 Mar; 68(9):262-5. PubMed ID: 5018121
    [No Abstract]   [Full Text] [Related]  

  • 7. [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
    BIRKMAYER W; HORNYKIEWICZ O
    Wien Klin Wochenschr; 1961 Nov; 73():787-8. PubMed ID: 13869404
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study].
    GERSTENBRAND G; PATEISKY K
    Wien Z Nervenheilkd Grenzgeb; 1962; 20():90-100. PubMed ID: 13947380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effects of L-dopa in Parkinson's disease].
    Fasano VA
    Sist Nerv; 1970; 22(2):119-23. PubMed ID: 5504550
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of Levo-Dopa in the treatment of Parkinsonism (188 cases)].
    Fasano VA; Urciuoli R; Broggi G; Lombard GF
    Minerva Neurochir; 1970; 14(2):245-9. PubMed ID: 5515308
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine metabolism in Parkinson's disease.
    GREER M; WILLIAMS CM
    Neurology; 1963 Jan; 13():73-6. PubMed ID: 13950225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Association of L-dopa and other therapeutic methods in treatment of parkinsonian syndromes].
    Mingrino S
    Sist Nerv; 1970; 22(2):212-5. PubMed ID: 4926920
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 14. New and OLD DRUGS FOR PARKINSONISM.
    Med Lett Drugs Ther; 1968 Sep; 10(18):69-72. PubMed ID: 5730145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mydocalm and muscle tone].
    DOBI S
    Ther Hung; 1961; 9():15-8. PubMed ID: 14028214
    [No Abstract]   [Full Text] [Related]  

  • 16. L-Dopa therapy in Parkinson's disease.
    Greer M
    J Fla Med Assoc; 1970 Jun; 57(6):23-7. PubMed ID: 4392779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of parkinsonism with L-dopa].
    Presthus J
    Nord Med; 1970 Nov; 84(46):1467-8. PubMed ID: 5479940
    [No Abstract]   [Full Text] [Related]  

  • 18. [The trial of intravenous L-DOPA in patients with Parkinson's disease].
    Nardini M; Fieschi C; Agnoli A; Arcioli I; Zanette E
    Riv Neurol; 1970; 40(2):75-85. PubMed ID: 5429003
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H
    Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.